RenovoRx (Nasdaq: RNXT)’s Post

RenovoRx today announced the appointment of internationally renowned interventional oncologist Thierry De Baere, MD, PhD to RenovoRx’s Scientific Advisory Board (SAB). Professor de Baère is a leading expert on targeted drug-delivery and locoregional cancer therapies, and his expertise will further strengthen our SAB. Learn more: https://bit.ly/4717k6c

  • No alternative text description for this image

To view or add a comment, sign in

Explore content categories